<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000648595"><TermName>Syk kinase inhibitor R-935788</TermName><TermPronunciation>(sik KY-nays in-HIH-bih-ter …)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer and certain other diseases, such as rheumatoid arthritis. It may block tumor cell signaling and growth. It is a type of tyrosine kinase inhibitor. Also called fostamatinib disodium and R788 sodium.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726159" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Syk kinase inhibitor R-935788&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726158" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la cinasa Syk R-935788&quot;" language="es" id="_4"/><SpanishTermName>inhibidor de la cinasa Syk R-935788</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer y ciertas otras enfermedades, como la artritis reumatoide.   Puede bloquear las señales y el crecimiento de células tumorales. Es un tipo de inhibidor de la tirosina cinasa.   También se llama fostamatinib disódico y R788 sódico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-01-11</DateFirstPublished></GlossaryTerm>
